Grifols (GIFLF) Minority Interest (2010 - 2021)
Grifols (GIFLF) reported Minority Interest of $2.3 billion for Q4 2021, up 22.07% on a YoY basis from $1.9 billion in Q4 2020, and up 22.07% quarter-over-quarter from $1.9 billion in Q4 2020.
Grifols (GIFLF) Minority Interest (2010 - 2021) Analysis & Trends
Grifols has reported Minority Interest for 12 years, with the latest figure at $2.3 billion in Q4 2021.
- For the quarter ending Q4 2021, Minority Interest rose 22.07% year-over-year to $2.3 billion; the trailing twelve-month figure through Dec 2021 stood at $2.3 billion (up 22.07% YoY), and the FY2021 full-year result was $2.3 billion, up 22.07% from the prior year.
- Minority Interest for Q4 2021 stood at $2.3 billion, up from $1.9 billion in the prior quarter.
- The five-year high for Minority Interest was $2.3 billion in Q4 2021, with the low at $2.7 million in Q3 2018.
- Historically, Minority Interest has averaged $1.0 billion across 5 years, with a median of $581.7 million in 2018.
- Annual changes were most pronounced in 2018 — Minority Interest slipped 27.92% — and 2019, when it soared 21123.12%.
- Grifols' Minority Interest stood at $5.8 million in 2017, then jumped by 9245.75% to $537.7 million in 2018, then jumped by 316.62% to $2.2 billion in 2019, then slipped by 14.21% to $1.9 billion in 2020, then climbed by 22.07% to $2.3 billion in 2021.
- The last three Minority Interest figures came in at $2.3 billion (Q4 2021), $1.9 billion (Q4 2020), and $2.1 billion (Q3 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn |
| 10 | Grifols | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.35 Bn |
| Dec 31, 2020 | 1.92 Bn |
| Sep 30, 2020 | 2.06 Bn |
| Mar 31, 2020 | 1.84 Bn |
| Dec 31, 2019 | 2.24 Bn |
| Sep 30, 2019 | 578.62 Mn |
| Dec 31, 2018 | 537.65 Mn |
| Sep 30, 2018 | 2.73 Mn |
| Jun 30, 2018 | 4.59 Mn |
| Mar 31, 2018 | 584.68 Mn |
| Dec 31, 2017 | 5.75 Mn |
| Jun 30, 2017 | 6.36 Mn |
| Dec 31, 2016 | 7.01 Mn |
| Sep 30, 2016 | 4.51 Mn |
| Jun 30, 2016 | 4.69 Mn |
| Dec 31, 2015 | 5.69 Mn |
| Sep 30, 2015 | 5.15 Mn |
| Jun 30, 2015 | 4,126.60 |
| Mar 31, 2015 | 4.75 Mn |
| Dec 31, 2014 | 5.96 Mn |